Literature DB >> 14605846

[Glomerular diseases in renal biopsy. Correlation of clinical syndromes with histological types].

H Nizze1, E Mann, G Stropahl, W Schmidt.   

Abstract

Renal biopsies studied by light and electron microscopy as well as by immunohistochemistry seem to be continually necessary for an adequate typing and therapy of glomerulonephritis (GN) and other glomerular diseases. Basing on 653 renal biopsies examined in Rostock from 1990 to 1999, the morphological classification in a total of 585 cases with glomerular diseases is presented in comparison to their clinical syndromes according to the WHO classification. A nephrotic syndrome was most frequent and clinically reported in 258 of the 585 biopsy cases with glomerular diseases (44%). It was seen in 77 of the 87 cases with minimal change nephropathy (55%), in 46 of the 74 cases with focal segmental glomerulosclerosis (62%), and in 19 of the 24 diffuse membranous GN cases (79%). The majority of the varying histological subtypes of diffuse GN was not combined with a specific clinical syndrome except of diffuse crescentic GN presenting with a rapidly progressive nephritic syndrome in 14 of 16 cases (88%). IgA nephropathy was the most often diagnosed entity of glomerular diseases found in 122 of the 502 cases with primary or secondary GN (24%). It is obvious that a given morphological GN type can but must not be combined with a specific clinical GN syndrome, so that the clinical importance of renal biopsy is stressed.

Entities:  

Mesh:

Year:  2003        PMID: 14605846     DOI: 10.1007/s00292-003-0647-4

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  12 in total

1.  Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis.

Authors:  D Kerjaschki
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

2.  [Glomerulonephritis].

Authors:  U Schmidt; J Franke; U Thomae; J Mann
Journal:  Internist (Berl)       Date:  2002-06       Impact factor: 0.743

3.  [Diagnostic errors in nephrology].

Authors:  A Schwarz; H Haller
Journal:  Internist (Berl)       Date:  2002-05       Impact factor: 0.743

Review 4.  Glomerulonephritis.

Authors:  D E Hricik; M Chung-Park; J R Sedor
Journal:  N Engl J Med       Date:  1998-09-24       Impact factor: 91.245

5.  A patient with microhematuria and proteinuria: do we still need electronmicroscopy?

Authors:  M J Mihatsch; H A Bock; F Gudat
Journal:  Nephrol Dial Transplant       Date:  1995-12       Impact factor: 5.992

6.  A modern classification of glomerulonephritis. A step forward for the pathologist.

Authors:  M J Mihatsch
Journal:  Pathol Res Pract       Date:  1979-04       Impact factor: 3.250

7.  [Fatal chronic oxalosis after sublethal ethylene glycol poisoning].

Authors:  H Nizze; P Schwabbauer; C Brachwitz; H Lange
Journal:  Pathologe       Date:  1997-07       Impact factor: 1.011

8.  Incidental healed postinfectious glomerulonephritis: a study of 1012 renal biopsy specimens examined by electron microscopy.

Authors:  Mark Haas
Journal:  Hum Pathol       Date:  2003-01       Impact factor: 3.466

9.  [Incidence of glomerular diseases in kidney biopsy materials using WHO classification].

Authors:  V V Serov; V A Varshavsky; H Schill; H Nizze
Journal:  Zentralbl Allg Pathol       Date:  1986

Review 10.  Diagnostic dilemmas in atypical postinfectious glomerulonephritis.

Authors:  Flora Sotsiou; George Dimitriadis; Helen Liapis
Journal:  Semin Diagn Pathol       Date:  2002-08       Impact factor: 3.464

View more
  2 in total

1.  Epidemiology of glomerulonephritis in Northern Germany.

Authors:  Norbert Braun; Anna Schweisfurth; Christine Lohöfener; Catalina Lange; Christian Gründemann; Günther Kundt; Hermann-Josef Gröne
Journal:  Int Urol Nephrol       Date:  2011-04-20       Impact factor: 2.370

2.  Epidemiological characteristics and pathological changes of primary glomerular diseases.

Authors:  Yan Li; XiaoYang Yu; WenJing Zhang; Jia Lv; Ping Lan; ZhiGang Wang; JiPing Sun; LiYi Xie; WanHong Lu; XueLiang Feng; Hongli Jiang; Yali Zhang
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.